Akèy › Neuromyelitis Optica
Etid klinik pou Neuromyelitis Optica ap rekrite nan Etazini
14 etid pou Neuromyelitis Optica ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
Pa eta
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT06680037Observational Safety Study in Women With Neuromyelitis Optica Spectrum Disorder (NMOSD) Exposed to UPLIZNA® During Pregnancy
Ap rekriteEtid obsèvasyon
Laj 15 ak plis · Fanm · Mizajou Aug 31, 2026 · NCT05909761A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
Ap rekriteFaz 3
Laj 2 a 11 · Tout sèks · Mizajou Aug 11, 2026 · NCT05199688Stem Cell Ophthalmology Treatment Study II
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 29, 2026 · NCT03011541Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Jun 18, 2026 · NCT05966467Longitudinal Cortical Demyelination in Multiple Sclerosis and Related Disorders
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jun 15, 2026 · NCT05982925Study of Ultomiris® (Ravulizumab) Safety in Pregnancy
Ap rekriteEtid obsèvasyon
Tout laj · Fanm · Mizajou Apr 16, 2026 · NCT06312644Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
Ap rekriteFaz 2
Laj 2 a 17 · Tout sèks · Mizajou Dec 5, 2025 · NCT05549258Efgartigimod for the Treatment of Acute Optic Neuritis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Nov 10, 2025 · NCT06453694Study of the Clinical and Radiological Impact of Ravulizumab in People With Neuromyelitis Optica Spectrum Disorder
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 5, 2025 · NCT06398158Biorepository and Registry for Plasma Exchange Patients
Ap rekriteEtid obsèvasyon
Laj 12 a 99 · Tout sèks · Mizajou May 20, 2025 · NCT05004493Impact of a Structured Wellness Behavioral Intervention on Quality of Life in NMOSD
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 17, 2025 · NCT06780709Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Apr 10, 2025 · NCT05566769MS-ResearchBiomarkerS
Ap rekriteEtid obsèvasyonVolontè an sante akeyiMande peman pou patisipan yo
Laj 18 ak plis · Tout sèks · Mizajou Feb 6, 2024 · NCT05204459Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.